- Home
- FBRX vs HBCP Comparison
FBRX vs HBCP Comparison
Compare FBRX & HBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBRX | HBCP |
|---|---|---|
| Founded | N/A | 1908 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.2M | 453.4M |
| IPO Year | 2017 | 2008 |
Fundamental Metrics
Financial Performance| Metric | FBRX | HBCP |
|---|---|---|
| Price | $19.12 | $64.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $67.00 | $65.50 |
| AVG Volume (30 Days) | ★ 178.8K | 62.3K |
| Earning Date | 05-14-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 1.98% |
| EPS Growth | ★ 61.30 | 29.01 |
| EPS | N/A | ★ 1.45 |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.97 |
| P/E Ratio | ★ N/A | $44.50 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.78 | $48.30 |
| 52 Week High | $35.80 | $66.00 |
Technical Indicators
Market Signals| Indicator | FBRX | HBCP |
|---|---|---|
| Relative Strength Index (RSI) | 32.53 | 54.75 |
| Support Level | $18.18 | $61.84 |
| Resistance Level | $34.44 | $65.86 |
| Average True Range (ATR) | 2.09 | 1.34 |
| MACD | -0.22 | 0.06 |
| Stochastic Oscillator | 5.88 | 62.34 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
About HBCP Home Bancorp Inc.
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities.It is holding company for Home Bank, N.A. The principal sources of funds are customer deposits, repayments of loans, repayments of investments, and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.